FY2028 Earnings Forecast for Myomo Issued By HC Wainwright

Myomo, Inc. (NYSEAMERICAN:MYO) – Stock analysts at HC Wainwright issued their FY2028 earnings per share (EPS) estimates for shares of Myomo in a report issued on Wednesday, November 13th. HC Wainwright analyst S. Lee forecasts that the company will earn $0.41 per share for the year. HC Wainwright has a “Buy” rating and a $7.50 price objective on the stock. The consensus estimate for Myomo’s current full-year earnings is ($0.17) per share.

Several other equities research analysts have also issued reports on the company. Craig Hallum started coverage on Myomo in a research note on Wednesday, July 31st. They set a “buy” rating and a $7.00 price objective for the company. Ascendiant Capital Markets increased their target price on Myomo from $8.50 to $9.00 and gave the company a “buy” rating in a report on Tuesday.

Myomo Price Performance

NYSEAMERICAN:MYO opened at $4.83 on Thursday. Myomo has a 1 year low of $2.51 and a 1 year high of $5.64. The firm has a market capitalization of $146.11 million, a price-to-earnings ratio of -20.43 and a beta of 1.56.

Myomo (NYSEAMERICAN:MYO) last announced its earnings results on Wednesday, November 6th. The company reported ($0.03) EPS for the quarter, beating the consensus estimate of ($0.04) by $0.01. The company had revenue of $9.21 million for the quarter, compared to analyst estimates of $7.95 million. Myomo had a negative return on equity of 86.30% and a negative net margin of 33.22%.

Institutional Investors Weigh In On Myomo

Institutional investors and hedge funds have recently bought and sold shares of the business. Rosalind Advisors Inc. grew its position in Myomo by 13.4% in the third quarter. Rosalind Advisors Inc. now owns 3,021,391 shares of the company’s stock worth $12,116,000 after acquiring an additional 356,392 shares in the last quarter. AIGH Capital Management LLC increased its position in shares of Myomo by 4.1% during the second quarter. AIGH Capital Management LLC now owns 2,917,997 shares of the company’s stock worth $9,367,000 after purchasing an additional 115,405 shares in the last quarter. Herr Investment Group LLC increased its position in shares of Myomo by 72.9% during the second quarter. Herr Investment Group LLC now owns 2,846,071 shares of the company’s stock worth $9,136,000 after purchasing an additional 1,200,244 shares in the last quarter. Essex Investment Management Co. LLC increased its position in shares of Myomo by 40.2% during the third quarter. Essex Investment Management Co. LLC now owns 899,135 shares of the company’s stock worth $3,606,000 after purchasing an additional 257,749 shares in the last quarter. Finally, GSA Capital Partners LLP grew its holdings in shares of Myomo by 60.8% during the third quarter. GSA Capital Partners LLP now owns 103,342 shares of the company’s stock valued at $414,000 after buying an additional 39,085 shares during the last quarter. 44.99% of the stock is owned by institutional investors.

Myomo Company Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient’s weak or paralyzed arm to enable and improve functional activities of daily living.